Investigation into Tandem Diabetes Care, Inc.
Rosen Law Firm, a prominent global advocate for investor rights, is actively pursuing potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM). This follows allegations suggesting that the company may have provided materially misleading business information to its investors.
Understanding Your Rights as an Investor
If you have purchased securities from Tandem Diabetes Care, you could be entitled to receive compensation. There's no need for out-of-pocket expenses through a contingency fee arrangement, meaning that you can seek justice without the financial burden. The Rosen Law Firm is assembling a class action aimed at recovering losses incurred by investors.
The Context of the Investigation
The situation arose when the company published a press release detailing a voluntary medical device correction for the t:slim X2 Insulin Pumps. This announcement came on a significant date when it was revealed that a potential issue with the product could lead to insulin delivery interruptions, which raised safety concerns.
Following this announcement on a day initially meant to build investor confidence, Tandem Diabetes' stock price plummeted by 19.9%. This decline signifies potential financial damages that affected numerous investors.
Choosing the Right Counsel
In times of uncertainty, it is crucial to seek legal counsel with an established record of success. Many law firms circulating notices may lack the necessary experience or resources to take on securities class actions effectively. The Rosen Law Firm not only shines in the field of investor representation but also boasts a track record that includes achieving the largest securities class action settlement involving a Chinese company. This knowledge can provide peace of mind to investors navigating their options.
Since 2013, the firm has consistently been ranked among the top representatives in securities class action settlements. With over $438 million secured for investors in 2019 alone, their commitment to recovering losses speaks volumes about their capabilities.
Founding partner Laurence Rosen's recognition as a Titan of the Plaintiffs' Bar further highlights the firm's dedication to advocacy and results. Many of their attorneys also carry accolades from notable legal directories, emphasizing their standing in the legal community.
Stay Informed
To remain updated on developments regarding this case, follow the Rosen Law Firm on various platforms including LinkedIn, Twitter, and Facebook. Engaging with their social media will provide timely information and insights into the progress of the investigation and class action.
Contact Information
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
www.rosenlegal.com
Frequently Asked Questions
What is the purpose of the investigation?
The investigation aims to determine if Tandem Diabetes Care provided misleading information to investors.
Who can join the class action?
Anyone who has purchased shares of Tandem Diabetes Care, Inc. may be entitled to join the class action.
What are contingency fees?
Contingency fees allow individuals to pursue legal action without upfront costs; attorneys are paid only if you win the case.
What happened on August 7, 2025?
The company announced a voluntary medical device correction, prompting a significant drop in their stock price.
Why should I select Rosen Law Firm?
Rosen Law Firm has an exemplary track record in securities class actions and offers experienced legal representation for investor claims.
